Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jinseisha is a Japan-based social welfare corporation that operates healthcare and elder-care facilities, including the Edogawa Group of Hospitals in Tokyo. The organization appears to be best known in English-language sources as the owner/operator of Edogawa Hospital and affiliated medical facilities, rather than as a drug-development biotech or pharmaceutical company. Its activities include hospital care, clinics, health screening, and social welfare services, and it has also been involved in initiatives to expand access to advanced cancer treatment in Tokyo. Public sources also link Jinseisha to the Edogawa NICHE Prize and to collaborations around regenerative medicine and proton therapy infrastructure. Based on available evidence, Jinseisha is a healthcare delivery organization, not a therapeutic product developer with a conventional biotech pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinseisha Trust.